AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dazirate ER 250 Tablet

Prescription Icon
Prescription Required

Marketer

Unistar Biotech Ltd

Salt Composition

Divalproex (250mg)

Overview Dazirate ER 250 Tablet

Epileptic seizures and migraine prevention are key uses for the extended-release formulation of the 250mg Dazirate tablet. It can also be employed in bipolar disorder management, sometimes as part of a broader treatment regimen. Dosage and frequency are determined individually by your physician to optimize symptom control. Administration with or without food is acceptable, but consistent daily timing is crucial for efficacy. Therapeutic effects typically manifest within a couple of weeks. Continuous use, as prescribed, is essential; discontinuing or missing doses elevates seizure risk and may worsen the underlying condition. Abrupt cessation is contraindicated. Common side effects, including headache, visual disturbances, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia, are usually mild. Persistent or bothersome effects should be reported to your doctor. Immediate medical attention is necessary if a skin rash or redness develops. Prolonged use carries a risk of osteoporosis and increased fracture likelihood. Suicidal ideation or behavior is a rare but serious potential adverse effect; report any mood changes to your doctor promptly. Prior to commencing treatment, inform your physician of any history of cardiovascular disease, renal or hepatic impairment, urinary difficulties, depression, or suicidal thoughts. Potential drug interactions exist; a comprehensive list of all medications should be provided to ensure treatment safety. Pregnant individuals should consult their doctor before initiating or discontinuing Dazirate ER 250. Alcohol consumption should be avoided due to the potential for intensified side effects and increased seizure risk. Regular blood tests may be required to monitor dosage efficacy, both pre- and post-treatment initiation.

Primary Ingredients of Dazirate ER 250 Tablet

No text provided. Please provide the text you would like me to rewrite.

Uses of Dazirate ER 250 Tablet

Managing epileptic seizures and bipolar disorder; migraine prevention.

Major Benefits of Dazirate ER 250 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dazirate ER 250 Tablets can be consumed with or without food; however, consistent daily timing is recommended.

Common Side effects of Dazirate ER 250 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Dazirate ER 250 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Dazirate ER 250 Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be administered with or without food, consistent timing is recommended for optimal results.

How Dazirate ER 250 Tablet works:

Epileptic seizures are managed by Dazirate ER 250mg, an anticonvulsant tablet. Its mechanism involves reducing hyperactivity within the brain's neuronal network.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Dazirate ER 250mg tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Dazirate 250 mg tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Dazirate 250 mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Dazirate ER 250 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney impairment can safely use Dazirate ER 250 Tablets without any required dose modification.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Dazirate ER 250 Tablet due to potential safety concerns. Medical advice is recommended.

What if you forget to take Dazirate ER 250 Tablet :

Should you forget a Dazirate ER 250 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Dazirate ER 250 Tablet

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Type of Therapy Neuroscience and the Central Nervous System
Actions Antiepileptic drugs targeting sodium channels

FAQs on Dazirate ER 250 Tablet

Always consult your doctor before discontinuing Dazirate ER 250 Tablet. Withdrawal should be gradual and supervised to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Dazirate ER 250 Tablets may be used to stabilize mood in individuals experiencing rapid mood swings. Its mechanism involves reducing excessive brain activity associated with these fluctuations.
Weight gain is a possible side effect of Dazirate ER 250 Tablet, potentially resulting from increased appetite. Maintain a healthy diet and exercise to mitigate this risk. Consult your doctor if you have concerns about weight changes.
Dazirate ER 250 Tablets may cause drowsiness. Refrain from driving or operating machinery until you understand the drug's effects on you.
Hair loss is a possible side effect of Dazirate ER 250 Tablet, typically temporary and related to dosage. Consult your doctor if this side effect concerns you or continues.
Dazirate ER 250 Tablet can cause liver damage, particularly within the first six months of treatment. Symptoms such as nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes) may indicate liver problems. Baseline liver function tests are recommended before starting the medication, with periodic testing during the initial six months, especially for high-risk individuals or those with a history of liver disease.
Refrain from drinking alcohol during your Dazirate ER 250 Tablet treatment. Combining alcohol with this medication can increase drowsiness, dizziness, and lightheadedness.
Before starting Dazirate ER 250 Tablet treatment, your doctor may order blood tests. These may include a complete blood count (with platelets), bleeding time, and coagulation studies to minimize the risk of bleeding or bruising. Liver function tests are also recommended before, and periodically during the first six months of treatment, especially for high-risk patients or those with a history of liver disease.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Dazirate ER 250 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Other symptoms may include muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Dazirate ER 250 Tablet
58
MRP 67
13% off